TransMedics Group, Inc. Earnings Per Share (Diluted)
TransMedics Group, Inc. (TMDX) reported Earnings Per Share (Diluted) of $0.41 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2026-08-04
- TransMedics Group, Inc. earnings per share, diluted for the quarter ending 2026-06-30 was $0.41, a 55.43% decline year-over-year.
- TransMedics Group, Inc. earnings per share, diluted for the quarter ending 2026-03-31 was $0.20, a 71.43% decline year-over-year.
- TransMedics Group, Inc. earnings per share, diluted for the quarter ending 2025-12-31 was $2.58, a 1222.70% increase year-over-year.
- TransMedics Group, Inc. earnings per share, diluted for the quarter ending 2025-09-30 was $0.66, a 450.00% increase year-over-year.
- TransMedics Group, Inc. earnings per share, diluted for fiscal 2025 was $4.87, a 382.18% increase from fiscal 2024.
- TransMedics Group, Inc. earnings per share, diluted for fiscal 2024 was $1.01.
- TransMedics Group, Inc. earnings per share, diluted for fiscal 2023 was -$0.77.
- TransMedics Group, Inc. earnings per share, diluted for fiscal 2022 was -$1.23.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.41 10-Q · filed 2026-08-04 | $0.61 10-Q · filed 2026-08-04 | $3.29 derived: net income ÷ weighted average shares · filed 2026-08-04 | $3.94 derived: net income ÷ weighted average shares · filed 2026-08-04 |
| 2026-03-31 | $0.20 10-Q · filed 2026-05-05 | $2.92 derived: net income ÷ weighted average shares · filed 2026-05-05 | $3.55 derived: net income ÷ weighted average shares · filed 2026-05-05 | $4.47 derived: net income ÷ weighted average shares · filed 2026-08-04 |
| 2025-12-31 | $2.58 derived: net income ÷ weighted average shares · filed 2026-02-24 | $3.24 derived: net income ÷ weighted average shares · filed 2026-02-24 | $4.16 derived: net income ÷ weighted average shares · filed 2026-08-04 | $4.87 10-K · filed 2026-02-24 |
| 2025-09-30 | $0.66 10-Q · filed 2025-10-29 | $1.58 derived: net income ÷ weighted average shares · filed 2026-08-04 | $2.28 10-Q · filed 2025-10-29 | $2.53 derived: net income ÷ weighted average shares · filed 2026-08-04 |
| 2025-06-30 | $0.92 10-Q · filed 2026-08-04 | $1.62 10-Q · filed 2026-08-04 | $1.87 derived: net income ÷ weighted average shares · filed 2026-08-04 | $2.02 derived: net income ÷ weighted average shares · filed 2026-08-04 |
| 2025-03-31 | $0.70 10-Q · filed 2026-05-05 | $0.93 derived: net income ÷ weighted average shares · filed 2026-05-05 | $1.06 derived: net income ÷ weighted average shares · filed 2026-05-05 | $1.40 derived: net income ÷ weighted average shares · filed 2026-05-05 |
| 2024-12-31 | $0.19 derived: net income ÷ weighted average shares · filed 2026-02-24 | $0.31 derived: net income ÷ weighted average shares · filed 2026-02-24 | $0.66 derived: net income ÷ weighted average shares · filed 2026-02-24 | $1.01 10-K · filed 2026-02-24 |
| 2024-09-30 | $0.12 10-Q · filed 2025-10-29 | $0.46 derived: net income ÷ weighted average shares · filed 2025-10-29 | $0.81 10-Q · filed 2025-10-29 | |
| 2024-06-30 | $0.35 10-Q · filed 2025-07-30 | $0.70 10-Q · filed 2025-07-30 | ||
| 2024-03-31 | $0.35 10-Q · filed 2025-05-08 | |||
| 2023-12-31 | -$0.77 10-K · filed 2026-02-24 | |||
| 2023-09-30 | -$0.78 10-Q · filed 2024-10-29 | -$0.89 10-Q · filed 2024-10-29 | ||
| 2023-06-30 | -$0.03 10-Q · filed 2024-08-01 | -$0.11 10-Q · filed 2024-08-01 | ||
| 2023-03-31 | -$0.08 10-Q · filed 2024-05-02 | |||
| 2022-12-31 | -$1.23 10-K · filed 2025-02-27 | |||
| 2022-09-30 | -$0.25 10-Q · filed 2023-11-08 | -$1.03 10-Q · filed 2023-11-08 | ||
| 2022-06-30 | -$0.41 10-Q · filed 2023-08-04 | -$0.79 10-Q · filed 2023-08-04 | ||
| 2022-03-31 | -$0.38 10-Q · filed 2023-05-04 | |||
| 2021-12-31 | -$1.60 10-K · filed 2024-02-27 | |||
| 2021-09-30 | -$0.47 10-Q · filed 2022-11-04 | -$1.14 10-Q · filed 2022-11-04 | ||
| 2021-06-30 | -$0.39 10-Q · filed 2022-08-03 | -$0.68 10-Q · filed 2022-08-03 | ||
| 2021-03-31 | -$0.29 10-Q · filed 2022-05-05 | |||
| 2020-12-31 | -$1.16 10-K · filed 2023-02-27 | |||
| 2020-09-30 | -$0.19 10-Q · filed 2021-11-09 | -$0.94 10-Q · filed 2021-11-09 | ||
| 2020-06-30 | -$0.36 10-Q · filed 2021-08-06 | -$0.78 10-Q · filed 2021-08-06 | ||
| 2020-03-31 | -$0.42 10-Q · filed 2021-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |